Reliance Industries navigates tough market conditions. Refining margins face volatility due to rising costs. Global crack spreads show improvement, but structural issues persist. The company’s consumer businesses present a mixed outlook. Retail revenue grows healthily, but margins are impacted by online segment expansion. Telecom also shows growth. Analysts provide insights into these ongoing trends.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.